CRP and metabolic syndrome: Despite these observations in this and other studies, it is not recommended for hs-CRP to be a suitable target for therapeutic intervention as no causal association between hs-CRP and MetS phenotypes has been reported.35 One platform to measure CRP, regardless of the clinical context, is ideal in the clinical laboratory as it could lead to decreased cost and turn-around-time of analysis, as most laboratories have dedicated instruments for measurement of hs-CRP and batch-analysis is usually performed.